• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

IR Biosciences Holdings Inc

UAZ2:GR

Ticker Delisted

Snapshot for IR Biosciences Holdings Inc (UAZ2)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for UAZ2

No chart data available.
  • UAZ2:GR
  • 1M
  • 1Y
0.000
Interactive UAZ2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UAZ2

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UAZ2

No data available

Company Profile & Key Executives for UAZ2

IR BioSciences Holdings, Inc., through its subsidiary, is a biotechnology company. The Company is involved in the research and development of applications utilizing modified Substance P, a naturally occuring immunomodulator. IR's initial focus is on the continuing development of Homspera for applications for use in improving pulmonary function and stimulating the human immune system.

Micheal K WilhelmPresident/CEOJohn N FermanisChief Financial Officer
Hal N SiegelVP/Chief Scientific OfficerChris A RomanoScientific Program Manager
More Company Profile & Key Executives for UAZ2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil